We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Saturday
May 13
15:15 - 16:15
Stolz 1
Prostate
Filippo Alongi, Italy;
William Kinnaird, United Kingdom
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will not be recorded.
1420
Mini-Oral
Clinical
Incidence and predictors of lower extremity lymphedema after post-prostatectomy radiotherapy
Giuseppe Facondo, Italy
MO-0215
Hypofractionated IGRT for prostate cancer: first report on toxicity of a phase III randomized trial
Ercole Mazzeo , Italy
MO-0216
Pattern of relapse following hypofractionated radiotherapy of IR prostate cancer in the PROFIT trial
Martin Lange, France
MO-0217
SABR with boost to the DIL in low-intermediate risk prostate cancer: a dose escalation trial
Paolo Bonome, Italy
MO-0218
Histopathology-validated detection rates of intraprostatic lesions with mpMRI, PSMA-PET and ACE-PET
Kristina Sandgren, Sweden
MO-0219
Two-year impact of bowel symptoms on HRQoL after RT for prostate cancer with pelvic node irradiation
Cesare Cozzarini, Italy
MO-0220
Intraprostatic GTV delineation in 18F-PSMA-PET Images for Patients with Primary PCa using a CNN
Julius Holzschuh, Germany
MO-0221